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General Approaches for Combining Multiple Rare Variant Associate Tests Provide
Improved Power Across a Wider Range of Genetic Architecture
Abstract
In the wake of the widespread availability of genome sequencing data made possible by way of
nextgeneration technologies, a flood of gene‐based rare variant tests have been proposed. Most methods
claim superior power against particular genetic architectures. However, an important practical issue
remains for the applied researcher—namely, which test should be used for a particular association study
which may consider multiple genes and/or multiple phenotypes. Recently, tests have been proposed
which combine individual tests to minimize power loss while improving the robustness to a wide range of
genetic architectures. In our analysis, we propose an expansion of these approaches, by providing a
general method that works for combining an arbitrarily large number of any gene‐based rare variant
test—a flexibility typically not available in other combined testing methods. We provide a theoretical
framework for evaluating our combined test to provide direct insights into the relationship between
test‐test correlation, test power and the combined test power relative to individual testing approaches
and other combined testing approaches. We demonstrate that our flexible combined testing method can
provide improved power and robustness against a wide range of genetic architectures. We further
demonstrate the performance of our combined test on simulated genotypes, as well as on a dataset of
real genotypes with simulated phenotypes. We support the increased use of flexible combined tests in
practice to maximize robustness of rare‐variant testing strategies against a wide‐range of genetic
architectures.
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IV. Results

I. Abstract
Over the past five years, numerous gene-based rare
variant tests of association have been proposed, each of
which attempt to combine variants within a gene or
region of interest into a single association statistic, with a
goal of providing more power than a strategy which
analyzes each variant separately. Simulation results have
shown that many of these individual tests provide good
power for particular genetic architectures, but not others.
We have developed a general strategy for combining any
two or more gene-based rare variant tests using an
adaptive approach, which yields a single p-value
representing the cumulative evidence for association
across the set of gene-based tests. For example this
strategy can take any threshold based test and turn it into
a variable-threshold test, combine similar tests (similar
statistic with alternative weighting strategies), or combine
substantially different tests (e.g., burden tests and
variance components tests). Using simulation we provide
guidance on the tradeoff between power gains and test
robustness versus the number of tests being combined, a
result which is based on the correlation structure of the
tests are under the null hypothesis of no association.
Finally, we demonstrate how recent results from our
group which suggested a substantially different genebased test which is robust to high proportions of noncausal variants, combined with other popular tests
(burden and variance component tests), can provide
improved power across a wider range of genetic
architecture.

II. Introduction
• Over the years, many tests of genotype-phenotype
association have been proposed , and recent work
has shown that different types of these tests are
more or less powerful under different genetic
architectures.
• Recent work by our group has classified these tests
into two groups: Length tests (also known as burden,
collapsing, and/or linear tests) and Joint tests
(alternatively, variance components or quadratic
tests). (Liu et al., 2013)
• Length tests can be powerful when the proportion of
causal variants in the region is large and the effects
of the causal variants tend to be similar. Joint tests
can be more powerful than length tests when there
are larger proportions of non-causal variants and
there is more variation in the effects of causal
variants (e.g., both risk increasing and risk-reducing
variants).
• Four recent papers have proposed combining test
statistics across both the length and joint classes to
yield more powerful test statistics (Derkach et al.,
2013; Lee, Wu, et al., 2012; Lee, Emond, et al.,
2012; Liu et al., 2013).
• Liu et al. (2013) also showed that length and joint
tests can be further classified by the norm, p, used in
the formulation of the test statistic. To date, most
length tests use p=1 and most joint tests use p=2.
Liu et al. demonstrate that higher choices of
norm provide increased robustness to large
proportions of non-causal variants.
• More general test-combining strategies (such as
combinations that include length and joint tests with
higher norms) may yield more powerful results when
the component tests being combined are powerful
for a wide range of genetic architectures.

III. Methods

Min(p) vs Bonferroni vs Fishers
• Across the 197 simulation settings and 12 combined
tests (2364 possibilities), there were only 10 times where
power of the Bonferroni approach exceeded the power of
the Min(p) approach and power gains were minimal
(ranging from 0.002 to 0.004) in these cases.
• Across 197 simulation settings, 36.5% of time Min(p) is
more powerful than Fishers
• Minimum p-value increases power when tests are very
different, but powerful in certain situations (if only 1 test
has a p-value of .001, but the others have p-values that
are very high, min-p works well)
• Fisher’s increases power when tests of different classes
all return low p-values (because it combines the
information).
Correlation structure between tests
• The performance of Min(p) and Fishers methods will be
affected by the correlation structure between the tests
(result of Sim. 1).

Description of the permutation strategy
• Derkach et al. (2012) propose an efficient
permutation strategy for assessing the significance
of S which we extend and apply here
• Utilize any number of rare variant tests.
• Find the minimum p-value of the tests..
• Through permutation, empirically find the distribution
of minimum p- values.
• Adjust the actual minimum p-value according to the
empirical distribution.
Rare variant tests
• List of individual tests considered: Sequence Kernel
Adaptive Test (SKAT); Sequence Kernel Adaptive
Test-Optimal (SKAT-O); Combined Multivariate and
Collapsing Test (CMC); Length tests with different
norms (L(p)); Joint tests with different norms (J(p));
Odds Ratio Weighted Sum Statistic (ORWSS)
• List of the combinations explored:

Table 1 – List of combined Tests Used Table 2 – Most Powerful Tests
Length tests with different
norms

L(1), L(2), L(4), L(∞)

Joint tests with different
norms

J(1), J(2), J(4), J(∞)

Variable threshold ORWSS

ORWSS(>0), ORWSS(<0),
ORWSS(≠0), ORWSS(>0),
ORWSS(<0), ORWSS(≠0),
ORWSS(>0), ORWSS(<0),
ORWSS(≠0)

Similar length tests

CMC, L(1)

Similar joint tests

SKAT, J(2)

Typical length-joint combined
test

SKAT, CMC

Length and joint tests across
norms

L(1), L(2), L(4), L(∞),(J(1),
J(2), J(4), J(∞))

Length and joint with some
norms

L(1), L(4), J(1), J(4)

Generic length-joint combined L(1), J(2)
test
Heterogeneous combined test CUMIT, ORWSS(>0),
#1
ORWSS(<0), ORWSS(≠0),
ORWSS(>0), ORWSS(<0),
ORWSS(≠0), ORWSS(>0),
ORWSS(<0), ORWSS(≠0),
L(1), L(2), L(4), L(∞),J(1),
J(2), J(4), J(∞)
Heterogeneous combined test SKAT-O, J(∞)
#2

Figure 1 – Heat Map of Combined Tests

Figure 1. To understand how the p-values between different tests are
correlated with each other we created a Heat Map of the p-values
between different tests across all simulation settings

Figure 2 – When Fishers generic combo(L1,J2) is more
powerful than L1(82.2% of sims) and
J2(37.5% of sims)

Heterogeneous combined test ORWSS(>0), ORWSS(<0),
#3
ORWSS(≠0), ORWSS(>0),
ORWSS(<0), ORWSS(≠0),
ORWSS(>0), ORWSS(<0),
ORWSS(≠0), L(1), L(2), L(4),
L(∞),J(1), J(2), J(4), J(∞)

Table 1. Left column gives name of combined test, right column lists the individual tests that
make up the combined test
Table 2. Lists percent of 197 simulations where a particular combined or individual test had
the highest power, or was within 5% of the most powerful test for that simulation setting.
The tests were ranked by how often they were within 5% of the most powerful test.

A) Simulations
Simulation Study # 1: Investigating the behavior of Min(p) and
Fisher’s
Simulation Study # 2: Investigating the behavior of combinations of
gene-based rare variant tests across different genetic disease
models
• 197 simulation settings, representing all possible combinations of
the following parameters:
(1) Number of single nucleotide variants (SNVs) (32 or 64)
(2) Proportion of non-causal SNVs (0, ¼, ½, ¾, 7/8, 15/16,
31/32, 63/64, 1)
(3) Proportion of causal SNVs that increase
disease risk (0, ¼, ½, ¾, 1), with the remaining causal
SNVs causing a decline in disease risk
(4) Relative risk of causal, risk increasing SNVs (1.1, 1.5 and
2.0); fixed the relative risk of risk-reducing SNVs at 0.5
(5) Minor allele frequencies simulated in 3:1 ratio of less
common (0.1% population MAF) to more common (1%
MAF), spread evenly across all non-causal and causal
SNVs.
• 500 samples generated at each simulation setting,
• Each individual and combined test applied to each sample (with
separate p-values for Min(p), Fisher’s, and Bonferonni for each
combined test).
• Empirical power estimates computed as percentage of p-values
less than 0.05 across the 500 samples.

Figure 3 – Hetero2 vs (L1,J2) Power on 80-98.4% Non
Causal Simulation Settings

Figure 3. Hetero2 has greater power than (L1,J2) 79.2% of sims
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